161 related articles for article (PubMed ID: 35324939)
1. Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico.
Vázquez-Cornejo E; Morales-Ríos O; Hernández-Pliego G; Cicero-Oneto C; Garduño-Espinosa J
PLoS One; 2022; 17(3):e0265450. PubMed ID: 35324939
[TBL] [Abstract][Full Text] [Related]
2. Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in Mexico.
Vázquez-Cornejo E; Morales-Ríos O; Juárez-Villegas LE; Islas Ortega EJ; Vázquez-Estupiñán F; Garduño-Espinosa J
Cancer Med; 2019 Oct; 8(13):5979-5987. PubMed ID: 31445000
[TBL] [Abstract][Full Text] [Related]
3. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
Kunac DL; Kennedy J; Austin N; Reith D
Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia.
West ZE; Castellino SM; Monroe C; Thomas AS; McCracken C; Miller TP
Leuk Lymphoma; 2021 Apr; 62(4):899-908. PubMed ID: 33258395
[TBL] [Abstract][Full Text] [Related]
5. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
[TBL] [Abstract][Full Text] [Related]
6. Adverse Events in Pediatric Inpatients: The Japan Adverse Event Study.
Sakuma M; Ohta Y; Takeuchi J; Yuza Y; Ida H; Bates DW; Morimoto T
J Patient Saf; 2024 Jan; 20(1):38-44. PubMed ID: 37922224
[TBL] [Abstract][Full Text] [Related]
7. Incidence trends of acute leukemia among the children of Mexico City: 1982-1991.
Mejía-Aranguré JM; Fajardo-Gutiérrez A; Bernáldez-Ríos R; Farfán-Canto JM; Ortíz-Fernández A; Martínez-García MD
Arch Med Res; 1996; 27(2):223-7. PubMed ID: 8696068
[TBL] [Abstract][Full Text] [Related]
8. Volume-Outcome Relationships in Pediatric Acute Lymphoblastic Leukemia: Association Between Hospital Pediatric and Pediatric Oncology Volume With Mortality and Intensive Care Resources During Initial Therapy.
Wilkes JJ; Hennessy S; Xiao R; Rheingold S; Seif AE; Huang YS; Vendetti N; Li Y; Bagatell R; Aplenc R; Fisher BT
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):404-410.e1. PubMed ID: 27246140
[TBL] [Abstract][Full Text] [Related]
9. [Incidence of acute leukemia in children in Mexico City, from 1982 to 1991].
Mejía-Aranguré JM; Fajardo-Gutiérrez A; Bernáldez-Ríos R; Paredes-Aguilera R; Flores-Aguilar H; Martínez-García MC
Salud Publica Mex; 2000; 42(5):431-7. PubMed ID: 11125628
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of healthcare associated infections in pediatric cancer patients between 2004 and 2009 in a public pediatric hospital in Mexico city, Mexico.
Hernández Orozco H; Lucas Resendiz E; Castañeda JL; De Colsa A; Ramirez Mayans J; Johnson KM; Gonzalez N; Caniza MA
J Pediatr Hematol Oncol; 2014 Mar; 36(2):96-8. PubMed ID: 23337552
[TBL] [Abstract][Full Text] [Related]
11. Incidence of malignant neoplasms in children attending Social Security Hospitals in Mexico City.
Fajardo-Gutiérrez A; Navarrete-Martínez A; Reynoso-García M; Zarzosa-Morales ME; Mejía-Aranguré M; Yamamoto-Kimura LT
Med Pediatr Oncol; 1997 Sep; 29(3):208-12. PubMed ID: 9212846
[TBL] [Abstract][Full Text] [Related]
12. Adverse Events in Long-term Care Residents Transitioning From Hospital Back to Nursing Home.
Kapoor A; Field T; Handler S; Fisher K; Saphirak C; Crawford S; Fouayzi H; Johnson F; Spenard A; Zhang N; Gurwitz JH
JAMA Intern Med; 2019 Sep; 179(9):1254-1261. PubMed ID: 31329223
[TBL] [Abstract][Full Text] [Related]
13. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology.
Pérez-Saldivar ML; Fajardo-Gutiérrez A; Bernáldez-Ríos R; Martínez-Avalos A; Medina-Sanson A; Espinosa-Hernández L; Flores-Chapa Jde D; Amador-Sánchez R; Peñaloza-González JG; Alvarez-Rodríguez FJ; Bolea-Murga V; Flores-Lujano J; Rodríguez-Zepeda Mdel C; Rivera-Luna R; Dorantes-Acosta EM; Jiménez-Hernández E; Alvarado-Ibarra M; Velázquez-Aviña MM; Torres-Nava JR; Duarte-Rodríguez DA; Paredes-Aguilera R; Del Campo-Martínez Mde L; Cárdenas-Cardos R; Alamilla-Galicia PH; Bekker-Méndez VC; Ortega-Alvarez MC; Mejia-Arangure JM
BMC Cancer; 2011 Aug; 11():355. PubMed ID: 21846410
[TBL] [Abstract][Full Text] [Related]
14. Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL).
Mejía-Aranguré E; Reyes-López A; Juárez-Villegas LE; Hernández-Olivares YO; Saucedo-Campos AD; Hernández-Pliego G; Martínez-Valverde S; Barajas-Nava LA; Garduño-Espinosa J
BMC Health Serv Res; 2022 Dec; 22(1):1522. PubMed ID: 36517861
[TBL] [Abstract][Full Text] [Related]
15. The incidence and severity of adverse events affecting patients after discharge from the hospital.
Forster AJ; Murff HJ; Peterson JF; Gandhi TK; Bates DW
Ann Intern Med; 2003 Feb; 138(3):161-7. PubMed ID: 12558354
[TBL] [Abstract][Full Text] [Related]
16. Exploring unplanned ICU admissions: a systematic review.
Vlayen A; Verelst S; Bekkering GE; Schrooten W; Hellings J; Claes N
JBI Libr Syst Rev; 2011; 9(25):925-959. PubMed ID: 27820505
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area.
Howard SC; Pedrosa M; Lins M; Pedrosa A; Pui CH; Ribeiro RC; Pedrosa F
JAMA; 2004 May; 291(20):2471-5. PubMed ID: 15161898
[TBL] [Abstract][Full Text] [Related]
18. Incidence and preventability of adverse events in adult patients admitted to a Brazilian teaching hospital.
Zanetti ACB; Dias BM; Bernardes A; Capucho HC; Balsanelli AP; Moura AA; Soato R; Gabriel CS
PLoS One; 2021; 16(4):e0249531. PubMed ID: 33857137
[TBL] [Abstract][Full Text] [Related]
19. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia.
Seif AE; Fisher BT; Li Y; Torp K; Rheam DP; Huang YS; Harris T; Shah A; Hall M; Fieldston ES; Kavcic M; Vujkovic M; Bailey LC; Kersun LS; Reilly AF; Rheingold SR; Walker DM; Aplenc R
Pediatr Blood Cancer; 2014 May; 61(5):846-52. PubMed ID: 24249480
[TBL] [Abstract][Full Text] [Related]
20. Preventability of Pediatric 30-Day Readmissions following Ventricular Shunt Surgery.
Tejedor-Sojo J; Singleton LM; McCormick K; Wrubel D; Chern JJ
J Pediatr; 2015 Dec; 167(6):1327-33.e1. PubMed ID: 26454576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
